MY173437A - A sanguisorba tannins extract, and preparation method and use thereof - Google Patents
A sanguisorba tannins extract, and preparation method and use thereofInfo
- Publication number
- MY173437A MY173437A MYPI2013000864A MYPI2013000864A MY173437A MY 173437 A MY173437 A MY 173437A MY PI2013000864 A MYPI2013000864 A MY PI2013000864A MY PI2013000864 A MYPI2013000864 A MY PI2013000864A MY 173437 A MY173437 A MY 173437A
- Authority
- MY
- Malaysia
- Prior art keywords
- extract
- sanguisorba
- preparation
- content
- less
- Prior art date
Links
- 229920001864 tannin Polymers 0.000 title abstract 3
- 239000001648 tannin Substances 0.000 title abstract 3
- 235000018553 tannin Nutrition 0.000 title abstract 3
- 244000173853 Sanguisorba officinalis Species 0.000 title abstract 2
- 235000008282 Sanguisorba officinalis Nutrition 0.000 title abstract 2
- 238000000605 extraction Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 210000001185 bone marrow Anatomy 0.000 abstract 2
- 229930190125 Sanguisorbin Natural products 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
A tannin extract of Sanguisorba officinalis L. contains tannin in a range of 35%-100% (w/w), wherein the content of total saponin is less than 10% (w/w), and the content of sanguisorbin I is less than 5% (w/w). The extract can protect bone marrow hematopoietic stem cells, relieve the inhibition of mouse bone marrow DNA caused by drugs for radiotherapy and chemotherapy, as well as increase numbers of leucocytes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010280772 | 2010-09-14 | ||
CN201110186932 | 2011-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY173437A true MY173437A (en) | 2020-01-24 |
Family
ID=45831012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2013000864A MY173437A (en) | 2010-09-14 | 2011-09-14 | A sanguisorba tannins extract, and preparation method and use thereof |
Country Status (5)
Country | Link |
---|---|
CN (3) | CN103948710A (en) |
GB (1) | GB2497899B (en) |
MY (1) | MY173437A (en) |
SG (2) | SG10201505752QA (en) |
WO (1) | WO2012034519A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223036A (en) * | 2013-04-16 | 2013-07-31 | 阚兆云 | Traditional Chinese medicinal composition |
CN104435220B (en) * | 2013-09-22 | 2018-01-05 | 成都百草和济科技有限公司 | Treat the combination medicine of bone marrow suppression |
CN104623015A (en) * | 2013-11-08 | 2015-05-20 | 成都百草和济科技有限公司 | New application of garden burnet root and India madder root composition |
GB201413228D0 (en) | 2014-07-25 | 2014-09-10 | Nugerontix Ltd | Polyphenol compositions |
CN105147804B (en) * | 2015-08-28 | 2019-04-09 | 四川英路维特医药科技有限公司 | A kind of radix sanguisorbae total saponin extract and its preparation method and application |
US10155069B2 (en) | 2016-09-09 | 2018-12-18 | King Abdulaziz University | Bone graft with a tannin-hydroxyapatite scaffold and stem cells for bone engineering |
CN112876523B (en) * | 2021-03-30 | 2023-07-25 | 江西海富生物工程有限公司 | Method for recovering tannic acid from fructus momordicae, sweet tea or stevia rebaudiana floc residues |
CN114577970B (en) * | 2022-02-18 | 2023-05-12 | 江西普正制药股份有限公司 | Method for establishing blood level tablet fingerprint and fingerprint thereof |
CN115232516B (en) * | 2022-06-27 | 2023-06-06 | 中南林业科技大学 | Anti-adhesion coating with camellia saponin as main component, preparation method thereof and application thereof in inhibiting bacillus cereus |
CN115998703B (en) * | 2022-12-14 | 2024-09-06 | 迪沙药业集团有限公司 | Sanguisorba composition and preparation method thereof |
CN116688012B (en) * | 2023-07-05 | 2024-06-04 | 浙江工业大学 | Buccal tablet for preventing influenza |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58103383A (en) * | 1981-12-12 | 1983-06-20 | Nippon Shinyaku Co Ltd | New tannin |
JPS58154571A (en) * | 1982-03-08 | 1983-09-14 | Nippon Shinyaku Co Ltd | Novel tannin |
CN1824631A (en) * | 2005-12-29 | 2006-08-30 | 谢君 | Molecular modification method of active fat soluble plant polyphenol kind substance |
JP5528025B2 (en) * | 2008-08-22 | 2014-06-25 | 花王株式会社 | TG synthesis inhibitor |
-
2011
- 2011-09-14 CN CN201410032898.0A patent/CN103948710A/en active Pending
- 2011-09-14 SG SG10201505752QA patent/SG10201505752QA/en unknown
- 2011-09-14 CN CN201410032553.5A patent/CN103784434A/en active Pending
- 2011-09-14 GB GB1306569.3A patent/GB2497899B/en active Active
- 2011-09-14 MY MYPI2013000864A patent/MY173437A/en unknown
- 2011-09-14 WO PCT/CN2011/079633 patent/WO2012034519A1/en active Application Filing
- 2011-09-14 CN CN2011800389315A patent/CN103079560A/en active Pending
- 2011-09-14 SG SG2013018692A patent/SG188529A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB201306569D0 (en) | 2013-05-22 |
CN103079560A (en) | 2013-05-01 |
CN103948710A (en) | 2014-07-30 |
CN103784434A (en) | 2014-05-14 |
SG188529A1 (en) | 2013-04-30 |
GB2497899B (en) | 2018-05-30 |
WO2012034519A1 (en) | 2012-03-22 |
GB2497899A (en) | 2013-06-26 |
SG10201505752QA (en) | 2015-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY173437A (en) | A sanguisorba tannins extract, and preparation method and use thereof | |
MX2010003934A (en) | Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium. | |
WO2012024530A3 (en) | Therapeutic peptide-polymer conjugates, particles, compositions, and related methods | |
WO2012159085A3 (en) | Compositions and methods for treating and preventing cancer by targeting and inhibiting cancer stem cells | |
MX2013012151A (en) | Method of inhibiting harmful microorganisms and barrier-forming composition therefor. | |
WO2012050396A3 (en) | Pharmaceutical composition including herbal medicine extract for preventing or treating liver cancer | |
WO2010095911A3 (en) | Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient | |
Jing-hua et al. | Effects of inoculating arbuscular mycorrhizal fungi on Artemisia annua growth and its officinal components. | |
MY183349A (en) | Use of lanostane and poria extract in treating diabetes | |
WO2014138426A3 (en) | Methods and compositions for reducing body fat and adipocytes | |
WO2012050398A3 (en) | Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer | |
WO2009090394A3 (en) | Composition containing capsicum for treating a skin disorder | |
NZ619634A (en) | Therapeutic composition and uses thereof | |
CR20200218A (en) | Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (cscs) by inhibiting mitochondrial respiration | |
WO2013033365A3 (en) | Stem cell compositions and methods | |
WO2012108749A3 (en) | Composition and health functional food for treating brain cancer comprising pharbitidis semen extract | |
CN104446920A (en) | Nutrient liquid capable of preventing and treating soft rot disease of dendrobium officinale | |
WO2011031890A3 (en) | Cancer stem cell-targeted and drug resistant cancer therapy | |
WO2011091154A3 (en) | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth | |
WO2012108748A3 (en) | Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract | |
CN104447081A (en) | Nutrient solution for preventing and curing diaspididae of dendrobii officmalis caulis | |
WO2012108747A3 (en) | Composition and cosmetic composition for treating brain cancer comprising helena root extract | |
MY170190A (en) | Use of a fermented soy extract as a prebiotic composition | |
WO2010129524A3 (en) | Plant medicinal compounds | |
WO2012134250A3 (en) | Composition for renal cancer treatment and composition for cosmetic containing nardostachyos rhizoma extract |